ALB and cancer: In addition to introducing a new type of hydrophobic monomer for the SI-PISA platform, this HSA-PMEMA micelle system offers a promising strategy for the development of convenient, safe, and efficient PTX delivery carriers for clinical use, with significant potential for improving the effect of cancer therapy.